TTP399: A Potential First-in-Class Adjunct Therapy in Type 1 Diabetes
Nearly 80 percent of people with type 1 diabetes (T1D) fail to meet HbA1c goals defined by the American Diabetes…
Saving Vision, Changing Lives
Several decades ago, type 1 diabetes (T1D) patients brought their seeing-eye dogs into the offices where Jennifer Sun, M.D., MPH.,…
Coronavirus and T1D: What You Should Know
First, don’t panic! Second, wash your hands and don’t touch your face. Third, understand the facts about managing T1D and…
A Scientist Sees Kidney Disease Through New Eyes
Monika Niewczas is keenly focused on kidneys. Specifically, making sure that they don’t stop working when someone develops type 1…
What is Autoimmune Disease?
It’s Autoimmune Disease Awareness Month, but what are autoimmune diseases? Good question. They occur when a person’s immune system mistakenly…
Collaboration and a Connection to T1D Researchers: Breakthrough T1D-nPOD Annual Meeting
I’ve just gotten back from the 12th Network for Pancreatic Organ Donors with Diabetes (nPOD) Annual Meeting, which was held…
Breakthrough T1D Receives Legacy Gift from the Estate of Marguerite Rosner
Generous donation furthers Breakthrough T1D mission to treat, prevent and find cures for type 1 diabetes.
New Breakthrough T1D-Funded Study finds Lifetime T1D Management Costs a Collective $813 Billion
Cost for each diagnosed American is nearly $500,000.
Two Long-Time Volunteers Elected to Lead Breakthrough T1D International Board of Directors
The Breakthrough T1D International Board of Directors (IBOD) named two long-time volunteers to serve as Chair and Vice Chair when…
ATTD Conference Brings Together Top Minds in Diabetes Research
Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments…
